Integral Diagnostics Ltd - Asset Resilience Ratio

Latest as of June 2018: 0.03%

Integral Diagnostics Ltd (IDX) has an Asset Resilience Ratio of 0.03% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Integral Diagnostics Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$55.00K

≈ $38.92K USD Cash + Short-term Investments

Total Assets

AU$195.53 Million

≈ $138.35 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how Integral Diagnostics Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Integral Diagnostics Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Integral Diagnostics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Integral Diagnostics Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$55.00K	0.03%
Total Liquid Assets	AU$55.00K	0.03%

Asset Resilience Insights

Limited Liquidity: Integral Diagnostics Ltd maintains only 0.03% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Integral Diagnostics Ltd Industry Peers by Asset Resilience Ratio

Compare Integral Diagnostics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Integral Diagnostics Ltd (2016–2023)

The table below shows the annual Asset Resilience Ratio data for Integral Diagnostics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-06-30	0.05%	AU$381.00K ≈ $269.58K	AU$839.01 Million ≈ $593.65 Million	0.00pp
2022-06-30	0.05%	AU$381.00K ≈ $269.58K	AU$783.01 Million ≈ $554.03 Million	0.00pp
2021-06-30	0.05%	AU$345.00K ≈ $244.11K	AU$654.90 Million ≈ $463.38 Million	-0.02pp
2020-06-30	0.07%	AU$401.00K ≈ $283.73K	AU$586.91 Million ≈ $415.28 Million	-0.03pp
2019-06-30	0.09%	AU$296.00K ≈ $209.44K	AU$314.67 Million ≈ $222.65 Million	+0.07pp
2018-06-30	0.03%	AU$55.00K ≈ $38.92K	AU$195.53 Million ≈ $138.35 Million	0.00pp
2017-06-30	0.03%	AU$56.00K ≈ $39.62K	AU$190.38 Million ≈ $134.71 Million	+0.01pp
2016-06-30	0.02%	AU$43.00K ≈ $30.43K	AU$181.10 Million ≈ $128.14 Million	--

pp = percentage points

About Integral Diagnostics Ltd

AU:IDX Australia Diagnostics & Research

Market Cap

$535.65 Million

AU$757.04 Million AUD

Market Cap Rank

#12022 Global

#309 in Australia

Share Price

AU$2.03

Change (1 day)

-1.93%

52-Week Range

AU$2.00 - AU$3.05

All Time High

AU$5.00